7Baggers
 AbbVie, BeOne end BTK blood cancer drug patent fight  Fierce Pharma Thu, 02 Oct 2025 14:29:16 GMT
 low grade glioma market growth to surge during forecast period  openPR.com Fri, 26 Sep 2025 15:50:04 GMT
 how to contact the daily bulletin  FinancialContent Tue, 23 Sep 2025 08:41:04 GMT
 united states esophageal cancer treatment market set  openPR.com Fri, 19 Sep 2025 07:22:51 GMT
 beigene(onc.us) officer sells us$3.26 million in common stock  富途牛牛 Sat, 13 Sep 2025 00:13:37 GMT
 beigene(onc.us) officer sells us$3.26 million in common stock  富途牛牛 Fri, 12 Sep 2025 07:00:00 GMT
 BeiGene stock falls on Trump EO concerns, RBC sees buying opportunity  Investing.com Thu, 11 Sep 2025 07:00:00 GMT
 rumored trump move rattles china-based biotech stocks  Investor's Business Daily Wed, 10 Sep 2025 19:55:00 GMT
 beigene ltd’s earnings call highlights strong growth  TipRanks Sun, 07 Sep 2025 00:04:24 GMT
 BeiGene Ltd’s Earnings Call Highlights Strong Growth  TipRanks Sat, 06 Sep 2025 07:00:00 GMT
 BeiGene Ltd’s Earnings Call Highlights Strong Growth  MSN Fri, 05 Sep 2025 07:00:00 GMT
 beigene to sell up to 4 million shares in employee share purchase plan  MarketScreener Thu, 04 Sep 2025 11:33:26 GMT
 taiwan's taiex index rises 0.6% to 24,235.27 at open  AInvest Thu, 04 Sep 2025 01:00:15 GMT
 celgene enters pd1 market with beigene deal  TheStreet Wed, 03 Sep 2025 18:38:30 GMT
 published on: 2025-09-03 17:36:48  خودرو بانک Wed, 03 Sep 2025 14:07:40 GMT
 john oyler: co-founder and ceo of beigene  Traders Union Fri, 29 Aug 2025 15:30:29 GMT
 beigene interim results swing into profit of us$95.59m  AASTOCKS.com Thu, 28 Aug 2025 10:01:00 GMT
 beone sells off amgen imdelltra royalties for $950m  BioWorld MedTech Tue, 26 Aug 2025 16:13:27 GMT
 finance watch: beone raises $885m in imdelltra royalty sale  insights.citeline.com Mon, 25 Aug 2025 22:24:21 GMT
 beone to get $885m upfront in royalty deal over amgen’s imdelltra  Endpoints News Mon, 25 Aug 2025 16:02:00 GMT
 royalty pharma buys beone stake in amgen lung cancer drug sales  BioPharma Dive Mon, 25 Aug 2025 07:00:00 GMT
 beone trades royalties on amgen's imdelltra for $885m upfront  FirstWord Pharma Mon, 25 Aug 2025 07:00:00 GMT
 published on: 2025-08-24 00:08:06  Newser Sun, 24 Aug 2025 05:08:06 GMT

BeiGene, Ltd
(NASDAQ:BGNE) 

BGNE stock logo

BeiGene, Ltd., a commercial-stage biotechnology company, engages in discovering, developing, manufacturing, and commercializing medicines for cancer therapeutics in the People's Republic of China and the United States. Its commercial products include BRUKINSA to treat relapsed/refractory (R/R) mantl...

Founded: 2010
Full Time Employees: 9,400 (Dec 2022)
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends